Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
Clinical trial NCT02522780 · COMPLETED
Trial details
- NCT number
- NCT02522780
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-09-19
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.